miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. [electronic resource]
Producer: 20120427Description: 796-805 p. digitalISSN:- 1096-9896
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Bone Neoplasms -- drug therapy
- Cell Line, Tumor
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Drug Synergism
- Humans
- Imidazoles -- pharmacology
- In Situ Hybridization
- Inhibitory Concentration 50
- Kaplan-Meier Estimate
- MicroRNAs -- metabolism
- Multivariate Analysis
- Oligonucleotide Array Sequence Analysis
- Paraffin Embedding
- Piperazines -- pharmacology
- Proportional Hazards Models
- Real-Time Polymerase Chain Reaction
- Reproducibility of Results
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sarcoma, Ewing -- drug therapy
- Time Factors
- Transfection
- Treatment Outcome
- Tumor Suppressor Protein p53 -- genetics
- Vincristine -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.